Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Schomburg_1994_Am.J.Clin.Onc_17_199

Reference

Title: Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy
Schomburg A, Kirchner H, Lopez-Hanninen E, Menzel T, Rudolph P, Korfer A, Fenner M, Poliwoda H, Atzpodien J
Ref: American Journal of Clinical Oncology, 17:199, 1994 : PubMed

        



Related information



Citations formats

Schomburg A, Kirchner H, Lopez-Hanninen E, Menzel T, Rudolph P, Korfer A, Fenner M, Poliwoda H, Atzpodien J (1994)
Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy
American Journal of Clinical Oncology 17: 199-209

Schomburg A, Kirchner H, Lopez-Hanninen E, Menzel T, Rudolph P, Korfer A, Fenner M, Poliwoda H, Atzpodien J (1994)
American Journal of Clinical Oncology 17: 199-209



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer